Skip to main content
Caplight Logo









Protogenix

Protogenix

Private
Ithaca, New YorkHealthcare & Life Scienceshttps://www.proto-genix.com/

Last Round

Accelerator

Feb 8, 2023

Total Funding Raised

$250,000

Company Overview

Protogenix is a biotechnology company that develops a plant-based molecular farming platform to produce complex animal proteins for food and pharmaceutical applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

biomanufacturingrecombinant proteinmolecular farmingalt-proteinprotein productionbioprocessingdecentralized manufacturingbiotech platformsustainable proteinlab-grown proteinprecision fermentationfood techbiotech R&Dpharma manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Protogenix Comparables

Compare Protogenix with similar companies based on industry and business-model similarity.

Protogenix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bright Biotech
79%
Seedling Biosystems Inc.
78%
Asterix Foods
75%

Protogenix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorFeb 8, 2023
AcceleratorJan 23, 2023

Protogenix Investors

Notable investors and investment history

Protogenix investors
InvestorRounds
IndieBioAccelerator
Kevin M. McGovern Family Center for Venture Development in the Life SciencesAccelerator
SOSVAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 23, 2023

    Received funding from Kevin M. McGovern Family Center for Venture Development.

Recent news

Latest coverage and updates

  • receives_financingJul 16, 2026

    Proto Genix received financing of $250K in venture funding on Feb 1st '26.

Protogenix Filings

Explore SEC and related filing metadata, where available.

Protogenix filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Protogenix's valuation, stock price, and market status.

Is Protogenix a public or private company?

Protogenix is a private company.

What is the current stock price of Protogenix?

Protogenix is a private company with no public stock price. No recent secondary market data is available.

How much is Protogenix worth (valuation)?

Valuation information for Protogenix is not publicly available.

Can I buy Protogenix stock?

Protogenix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Protogenix's last funding round?

Funding round information for Protogenix is not publicly available.

Who are the main investors in Protogenix?

Investor information for Protogenix is not publicly disclosed.

Will Protogenix IPO soon?

No public IPO plans have been announced for Protogenix.

How can I track Protogenix secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Protogenix's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIthaca, New York
Employee Range1
Year Founded2021
Last FundingFeb 8, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?